drugset / Trial / NCT00631488
A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will test the effectiveness and safety of treatment with MK-0893 in combination with other drugs commonly used to treat type 2 diabetes for a duration up to 13 weeks.
Timeline
- Start
- 2008-02
- Primary completion
- 2009-01
- Completion
- 2009-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0893 | Small molecule | 40 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
| Subject | Sitagliptin | Small molecule | 100 mg | Oral |